Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1989-05-30
1991-01-08
Robinson, Allen J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
A61R 3166
Patent
active
049835939
ABSTRACT:
A pharmaceutical composition comprising: a 1:1 solvate of 5-(5,5-dimethyl-1,3,2-dioxaphosphorinane-2-yl)-1,4-dihydro-2,6-dimethyl-4- (3- itrophenyl)-3-pyridine carboxylic acid 2-(phenylmethyl)amino) ethyl ester P-oxide hydrochloride-thanol (NZ-105) and hydroxypropylmethylcellulose acetate succinate is disclosed. the composition can easily be prepared into tablets, capsules, granules, and powders, which exhibit an enhanced bioavailability, e.g. provides a high blood concentration of the active component NZ-105 and ensures a high total drug absorption.
REFERENCES:
Chemical and Pharmaceutical Bulletin, vol. 35, No. 9, Sep. 1987, pp. 3935-3939, Pharmaceutical Society of Japan, Tokyo, JP; N. Ohnishi et al.
Miyajima Masaharu
Oda Toshihisa
Tsunematsu Takao
Yamaguchi Yukiya
Nissan Chemical Industries Ltd.
Robinson Allen J.
Zeria Pharmaceutical Co
LandOfFree
Pharmaceutical composition of dihydropyridine compound does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition of dihydropyridine compound, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition of dihydropyridine compound will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-934924